{
    "ucits": true,
    "type": "ETP",
    "leverage": true,
    "derivatives": true,
    "swaps": false,
    "inverse": true,
    "replication_method": "synthetic",
    "complex_factors": [
        "Leverage factor of 3x daily short exposure",
        "Synthetic replication via derivatives",
        "Use of futures contracts with roll costs and compounding effects",
        "Leveraged short strategy with daily reset and compounding",
        "Potential counterparty and collateral risks implicit in derivatives",
        "High risk rating (7/7) indicating high volatility and risk",
        "Complex payoff profile due to leverage and short exposure"
    ],
    "classification": "complex",
    "supporting_data": "The WisdomTree FTSE 100 3x Daily Short product is a UCITS-eligible Exchange Traded Product (ETP) designed to provide leveraged short exposure (-3x daily) to the FTSE 100 index. It uses a synthetic replication method involving futures contracts and derivatives to achieve this exposure. The product resets its leverage daily, causing compounding effects that make its performance over periods longer than one day deviate significantly from the simple leveraged index return. This daily reset and leverage introduce complexity in understanding the payoff and risks, including counterparty and collateral risks inherent in derivatives. The product is classified as high risk (7/7) and is intended for informed investors with specific knowledge and experience. The use of leverage beyond UCITS limits, synthetic replication, and the complex payoff structure with daily resets and compounding effects all contribute to the product being classified as complex under MiFID II. According to MiFID II Article 254, Delegated Regulation EU 2017/565 Article 57, and ESMA guidelines, such features override the baseline UCITS presumption of non-complexity. Therefore, this product requires an appropriateness assessment before being sold to retail investors and must include a comprehension alert in its PRIIPs KID."
}